Literature DB >> 18658202

Polymyalgia rheumatica vs late-onset rheumatoid arthritis.

M Cutolo, M A Cimmino, A Sulli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18658202     DOI: 10.1093/rheumatology/ken294

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

Review 1.  Prescribing for polymyalgia rheumatica.

Authors:  David F Liew; Claire E Owen; Russell R Buchanan
Journal:  Aust Prescr       Date:  2018-02-01

2.  Imbalance Between Omega-6- and Omega-3-Derived Bioactive Lipids in Arthritis in Older Adults.

Authors:  Roxana Coras; Brian Pedersen; Rekha Narasimhan; Anahy Brandy; Lourdes Mateo; Agueda Prior-Español; Arthur Kavanaugh; Aaron M Armando; Mohit Jain; Oswald Quehenberger; Melania Martínez-Morillo; Monica Guma
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-02-25       Impact factor: 6.053

3.  Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis.

Authors:  Frank Buttgereit; Gisela Doering; Achim Schaeffler; Stephan Witte; Stanislaw Sierakowski; Erika Gromnica-Ihle; Slawomir Jeka; Klaus Krueger; Jacek Szechinski; Rieke Alten
Journal:  Ann Rheum Dis       Date:  2010-06-11       Impact factor: 19.103

Review 4.  Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment.

Authors:  Maurizio Cutolo; Rainer H Straub
Journal:  Arthritis Res Ther       Date:  2009-04-06       Impact factor: 5.156

5.  The Role of Tumor Necrosis Factor Alpha Antagonists (Anti TNF-α) in Personalized Treatment of Patients with Isolated Polymyalgia Rheumatica (PMR): Past and Possible Future Scenarios.

Authors:  Ciro Manzo; Elvis Hysa; Alberto Castagna; Marco Isetta
Journal:  J Pers Med       Date:  2022-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.